A practical guide for nephrologist peer reviewers: evaluating artificial intelligence and machine learning research in nephrology.

IF 3 3区 医学 Q1 UROLOGY & NEPHROLOGY
Renal Failure Pub Date : 2025-12-01 Epub Date: 2025-07-07 DOI:10.1080/0886022X.2025.2513002
Yanni Wang, Wisit Cheungpasitporn, Hatem Ali, Jianbo Qing, Charat Thongprayoon, Wisit Kaewput, Karim M Soliman, Zhengxing Huang, Min Yang, Zhongheng Zhang
{"title":"A practical guide for nephrologist peer reviewers: evaluating artificial intelligence and machine learning research in nephrology.","authors":"Yanni Wang, Wisit Cheungpasitporn, Hatem Ali, Jianbo Qing, Charat Thongprayoon, Wisit Kaewput, Karim M Soliman, Zhengxing Huang, Min Yang, Zhongheng Zhang","doi":"10.1080/0886022X.2025.2513002","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) and machine learning (ML) are transforming nephrology by enhancing diagnosis, risk prediction, and treatment optimization for conditions such as acute kidney injury (AKI) and chronic kidney disease (CKD). AI-driven models utilize diverse datasets-including electronic health records, imaging, and biomarkers-to improve clinical decision-making. Applications such as convolutional neural networks for kidney biopsy interpretation, and predictive modeling for renal replacement therapies underscore AI's potential. Nonetheless, challenges including data quality, limited external validation, algorithmic bias, and poor interpretability constrain the clinical reliability of AI/ML models. To address these issues, this article offers a structured framework for nephrologist peer reviewers, integrating the TRIPOD-AI (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis-AI Extension) checklist. Key evaluation criteria include dataset integrity, feature selection, model validation, reporting transparency, ethics, and real-world applicability. This framework promotes rigorous peer review and enhances the reproducibility, clinical relevance, and fairness of AI research in nephrology. Moreover, AI/ML studies must confront biases-data, selection, and algorithmic-that adversely affect model performance. Mitigation strategies such as data diversification, multi-center validation, and fairness-aware algorithms are essential. Overfitting in AI is driven by small patient cohorts faced with thousands of candidate features; our framework spotlights this imbalance and offers concrete remedies. Future directions in AI-driven nephrology include multimodal data fusion for improved predictive modeling, deep learning for automated imaging analysis, wearable-based monitoring, and clinical decision support systems (CDSS) that integrate comprehensive patient data. A visual summary of key manuscript sections is included.</p>","PeriodicalId":20839,"journal":{"name":"Renal Failure","volume":"47 1","pages":"2513002"},"PeriodicalIF":3.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239107/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Renal Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/0886022X.2025.2513002","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) and machine learning (ML) are transforming nephrology by enhancing diagnosis, risk prediction, and treatment optimization for conditions such as acute kidney injury (AKI) and chronic kidney disease (CKD). AI-driven models utilize diverse datasets-including electronic health records, imaging, and biomarkers-to improve clinical decision-making. Applications such as convolutional neural networks for kidney biopsy interpretation, and predictive modeling for renal replacement therapies underscore AI's potential. Nonetheless, challenges including data quality, limited external validation, algorithmic bias, and poor interpretability constrain the clinical reliability of AI/ML models. To address these issues, this article offers a structured framework for nephrologist peer reviewers, integrating the TRIPOD-AI (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis-AI Extension) checklist. Key evaluation criteria include dataset integrity, feature selection, model validation, reporting transparency, ethics, and real-world applicability. This framework promotes rigorous peer review and enhances the reproducibility, clinical relevance, and fairness of AI research in nephrology. Moreover, AI/ML studies must confront biases-data, selection, and algorithmic-that adversely affect model performance. Mitigation strategies such as data diversification, multi-center validation, and fairness-aware algorithms are essential. Overfitting in AI is driven by small patient cohorts faced with thousands of candidate features; our framework spotlights this imbalance and offers concrete remedies. Future directions in AI-driven nephrology include multimodal data fusion for improved predictive modeling, deep learning for automated imaging analysis, wearable-based monitoring, and clinical decision support systems (CDSS) that integrate comprehensive patient data. A visual summary of key manuscript sections is included.

Abstract Image

Abstract Image

肾病专家同行评审的实用指南:评估肾脏病学中的人工智能和机器学习研究。
人工智能(AI)和机器学习(ML)通过增强急性肾损伤(AKI)和慢性肾脏疾病(CKD)等疾病的诊断、风险预测和治疗优化,正在改变肾脏病学。人工智能驱动的模型利用各种数据集——包括电子健康记录、成像和生物标志物——来改善临床决策。诸如用于肾脏活检解释的卷积神经网络和用于肾脏替代治疗的预测建模等应用强调了人工智能的潜力。然而,包括数据质量、有限的外部验证、算法偏差和较差的可解释性在内的挑战限制了AI/ML模型的临床可靠性。为了解决这些问题,本文为肾病专家同行评审提供了一个结构化框架,整合了TRIPOD-AI(透明报告个体预后或诊断的多变量预测模型- ai扩展)清单。关键评估标准包括数据集完整性、特征选择、模型验证、报告透明度、道德规范和现实世界的适用性。该框架促进了严格的同行评议,提高了肾脏学人工智能研究的可重复性、临床相关性和公平性。此外,AI/ML研究必须面对偏见-数据,选择和算法-这些偏见会对模型性能产生不利影响。缓解策略,如数据多样化、多中心验证和公平感知算法是必不可少的。人工智能中的过度拟合是由面对数千个候选特征的小患者队列驱动的;我们的框架突出了这种不平衡,并提供了具体的补救措施。人工智能驱动肾脏病学的未来发展方向包括用于改进预测建模的多模态数据融合、用于自动成像分析的深度学习、基于可穿戴设备的监测以及集成综合患者数据的临床决策支持系统(CDSS)。关键手稿部分的视觉总结包括在内。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Renal Failure
Renal Failure 医学-泌尿学与肾脏学
CiteScore
3.90
自引率
13.30%
发文量
374
审稿时长
1 months
期刊介绍: Renal Failure primarily concentrates on acute renal injury and its consequence, but also addresses advances in the fields of chronic renal failure, hypertension, and renal transplantation. Bringing together both clinical and experimental aspects of renal failure, this publication presents timely, practical information on pathology and pathophysiology of acute renal failure; nephrotoxicity of drugs and other substances; prevention, treatment, and therapy of renal failure; renal failure in association with transplantation, hypertension, and diabetes mellitus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信